
After the health service struggled through the same period last year, Amber Jabbal, Head of Policy at NHS Providers sets …

During the release of Q3 figures, GlaxoSmithKline’s CEO, Emma Walmsley, revealed that the company would consider making moves to bolster …

Following the recent revelation that Pfizer was considering the spin-out of its consumer health division, it has now emerged that …

In a sign of how desperate the hospital bed situation across the UK is, one council has looked into piloting …

Sanofi subsidiary Regeneron has announced its intention to expand its production plant in Limerick, Ireland – the largest scale bulk …

A report commissioned by Prime Minister, Theresa May, has found that 300,000 people are leaving their positions of work after …

Sanofi has launched a lawsuit against Mylan as part of a dispute that alleges that the latter infringed upon 18 …

Eli Lilly released its Q3 financials and the major talking point was the announcement that the business was reviewing “strategic …

GSK has received good news from NICE as it is revealed that Strimvelis, its gene therapy treatment for adenosine deaminase …

Blood-thinning drugs are commonly used to reduce stroke risk in patients with atrial fibrillation (AF) but research from the Karolinska …

In the first ever study of its kind, researchers from the University of Surrey examined the records of more than …

Novartis released its Q3 financials and, despite Gleevec dipping significantly due to generic competition, still managed to report sales of …

Gilead had revealed that it has promoted Dr Alessandro Riva, its Senior Vice President, Hematology and Oncology Therapeutic Area Head, …

New findings of a report by PwC have revealed the biggest spenders in R&D worldwide as global spending hits $700 …

Drug developers investigating Alzheimer’s drugs know that they’re taking a gamble; there have been numerous big failures that have caused …

ADC Therapeutics has won some serious financial support after its latest financing round managed to net the company $200 million. …

The November edition of Pharmafocus is now live and available to read online here!

Recipharm, a leading contract development and manufacturing organisation (CDMO) has equipped its sixth facility with serialisation capabilities ahead of the …

Ben Hargreaves examines the emerging practical and technological solutions that are aiming to improve patients’ access to medicines in a …

A new report published by STOP AIDS and Global Justice Now takes aim at three pharmaceutical companies who have taken …